{
  "docId": "019de511-70b9-744d-9fdd-cb0d25e1c298",
  "docSlug": "65af9093c9ec9ca745928fa125179681",
  "documentTitle": "Avantor | Investor Day Presentation Deck | 89 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 89,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "timeline",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a horizontal timeline to categorize therapeutic modalities into Small Molecule, Biologics, and Viral Vector/Cell & Gene therapy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-70b9-744d-9fdd-cb0d25e1c298/28",
  "deckHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298",
  "deckJsonHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298.json",
  "deckAnchorHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Timeline of therapeutic platforms from 1800s to 2020s",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1edbe9b-0bff-4934-8c29-4e2e19b1df47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.03,
        "y": 0.01
      },
      "kind": "other",
      "text": "3. BIOPRODUCTION",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7f9c9c0-62cd-4030-81c2-a50c1356320f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Avantor well positioned to gain market share throughout the workflow",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d3ebf7d-be5b-4fa1-81ac-f2bfa1c0d3e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Rapid evolution of new platforms",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cae98f8-7e14-4ab6-b64d-0c4e4598b739",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "caa544eb-4f42-407d-b167-05db58ceb336",
      "evidence": "Chronological progression of therapeutic platforms",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 89,
      "from": 17,
      "beatId": "2aa3ce3e-d4bb-4cda-b13e-25db1a3054af",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Growth prospects and financial highlights",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 40,
      "from": 21,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "44a7c149-2da8-4925-9541-064336919963",
      "evidence": "Case study and supporting data",
      "position": 0,
      "objective": "Show how Avantor's offering supports Biopharma R&D activities",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}